Daily Dose - Oct 28th, 2026
Daily Dose |
View online
October 28, 2026
Lonza sees bioconjugation as a gap in its US network, potential area of investment
The market remains very attractive but undersupplied, according to the Switzerland-headquartered contract development and manufacturing organization.
Read More
Made Scientific partners with CARR to scale cell therapy manufacturing
CARR’s single-use centrifugation platform will support process volumes from milliliters to more than 2,000 liters, according to the companies.
Read More
Abionyx, Axplora team on purification for investigational biologic
The agreement assigns recombinant human apoA-I purification to Axplora’s site in France, completing the planned manufacturing network.
Read More
